These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9661588)

  • 21. Osteoporosis, genetics and hormones.
    Rizzoli R; Bonjour JP; Ferrari SL
    J Mol Endocrinol; 2001 Apr; 26(2):79-94. PubMed ID: 11241160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bone mineral density measurements for diagnosis of osteoporosis and the risk assessment].
    Kushida K
    Clin Calcium; 2004 Dec; 14(12):11-7. PubMed ID: 15577168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone quality--the material and structural basis of bone strength and fragility.
    Seeman E; Delmas PD
    N Engl J Med; 2006 May; 354(21):2250-61. PubMed ID: 16723616
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of osteoporosis with Teriparatide rhPTH(1-34).
    San Martin J
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):406. PubMed ID: 15758281
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of osteoporosis and fractures.
    Ullom-Minnich P
    Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Osteoporosis is prevented by physical activity, calcium and hormone supplementation].
    Piehl-Aulin K; Brahm H
    Lakartidningen; 1999 Jan; 96(3):210-4. PubMed ID: 10068323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone microdamage and skeletal fragility in osteoporotic and stress fractures.
    Burr DB; Forwood MR; Fyhrie DP; Martin RB; Schaffler MB; Turner CH
    J Bone Miner Res; 1997 Jan; 12(1):6-15. PubMed ID: 9240720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between fat and bone.
    Reid IR
    Osteoporos Int; 2008 May; 19(5):595-606. PubMed ID: 17965817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Osteoporosis from the gynecologic viewpoint].
    Schneider HP; Dören M
    Gynakologe; 1993 Apr; 26(2):83-92. PubMed ID: 8508989
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone quality: understanding what matters.
    Burr DB
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):184-6. PubMed ID: 15615122
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
    Felsenberg D; Boonen S
    Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of the osteoporoses.
    Axelrod DW
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):15S-19S. PubMed ID: 9273932
    [No Abstract]   [Full Text] [Related]  

  • 38. [What is reliable in the treatment of osteoporosis in menopausal women?].
    Ziegler R
    Internist (Berl); 1993 Jan; 34(1):18-24. PubMed ID: 8440570
    [No Abstract]   [Full Text] [Related]  

  • 39. Periosteal bone formation--a neglected determinant of bone strength.
    Seeman E
    N Engl J Med; 2003 Jul; 349(4):320-3. PubMed ID: 12878736
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bone remodeling].
    Lerner UH; Ljunggren O
    Lakartidningen; 2006 Oct 4-10; 103(40):2972-5. PubMed ID: 17115661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.